Mirum Pharmaceuticals, Inc. MIRM Finished goods
Finished goods at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s finished goods.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s finished goods?
- Mirum Pharmaceuticals, Inc. (MIRM) reported finished goods of $3.42M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s finished goods changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s finished goods decreased by 4.4% year-over-year, from $3.58M to $3.42M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s finished goods?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s finished goods has grown at a -39.0% compound annual growth rate (CAGR), from $9.44M to $3.52M.
- What does finished goods mean?
- Completed products ready for sale, valued at the lower of cost or net realizable value.